"Ons logo, dat de vorm van een hart aanneemt, staat letterlijk voor een hartelijke en menselijke omgeving. Een omgeving waarin elk leven telt. Onze baseline ‘Dicht bij het leven’ sluit daar perfect bij aan. In weinig woorden drukken we er de ziel van Az Damiaan mee uit, waar liefdevol voor elk leven wordt gezorgd. Dat kunnen we waarmaken door elke patiënt een centrale plaats te geven in ons hedendaagse, hoogtechnologische en patiëntvriendelijke ziekenhuis. Wil jij graag werken in ons ziekenhuis? In onze bekroonde mini-serie ‘Ostenders’ ontdek je meteen de fantastische werksfeer (www.ostenders.be). Met onze cast van meer dan 100 artsen en 1.400 medewerkers maken we elke dag topafleveringen. Word ook een #Ostender!"

During the past decade, AZ Damiaan conducted 26 clinical trials. In the 10-year time frame, 26 clinical trials started and 10 clinical trials were completed, i.e. on average, 38.5% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 5 clinical trials were completed. i.e. 38.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "AZ Damiaan" #1 sponsor was "Hoffmann-La Roche" with 8 trials, followed by "Eli Lilly and Company" with 4 trials sponsored, "European Organisation for Research and Treatment of Cancer - EORTC" with 4 trials sponsored, "Pfizer" with 3 trials sponsored and "University Hospital, Ghent" with 3 trials sponsored. Other sponsors include 18 different institutions and companies that sponsored additional 25 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "AZ Damiaan" #1 collaborator was "Breast International Group" with 2 trials as a collaborator, "Hoffmann-La Roche" with 2 trials as a collaborator, "Takeda" with 2 trials as a collaborator, "Universiteit Antwerpen" with 2 trials as a collaborator and "AZ Damiaan, Oostende" with 1 trials as a collaborator. Other collaborators include 44 different institutions and companies that were collaborators in the rest 54 trials.

According to Clinical.Site data, the most researched conditions in "AZ Damiaan" are "Breast Cancer" (5 trials), "Rheumatoid Arthritis" (4 trials), "Crohn Disease" (3 trials), "Prostate Cancer" (3 trials) and "Cardiovascular Disease" (2 trials). Many other conditions were trialed in "AZ Damiaan" in a lesser frequency.

Most popular intervention types in "AZ Damiaan" are "Drug" (30 trials), "Other" (8 trials), "Device" (4 trials), "Genetic" (2 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Tirzepatide" (4 trials), "Carboplatin" (3 trials), "Dulaglutide" (2 trials) and "Paclitaxel" (2 trials). Other intervention names were less common.

The vast majority of trials in "AZ Damiaan" are 33 trials for "All" genders, 6 trials for "Female" genders and 6 trials for "Male" genders.

Currently, there are NaN active trials in "AZ Damiaan". undefined are not yet recruiting, 9 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 24 completed trials in AZ Damiaan, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in AZ Damiaan, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 6 trials that are defined as “Not Applicable".